30.20
price down icon7.11%   -2.31
pre-market  Pre-mercato:  29.60   -0.60   -1.99%
loading

Vaxcyte Inc Azioni (PCVX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
41.80%
114.47
196.68 113.03 87.15 71.19
Depreciation and Amortization
11.11%
1.00
0.90 0.80 0.80 0.70
Operating Income/Loss
41.80%
-114.47
-196.68 -113.03 -87.15 -71.19
Income/Loss From Continuing Operations Before Tax
47.44%
-95.02
-180.80 -92.66 -68.34 -60.46
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
47.44%
-95.02
-180.80 -92.66 -68.34 -60.46
Net Income/Loss
47.44%
-95.02
-180.80 -92.66 -68.34 -60.46
Preferred Stock Dividends And Other Adjustments
100.00%
-
442.93 -185.33 - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
6,140%
111.69
1.7899 101.67 98.06 86.21
Diluted Average Shares
6,140%
111.69
1.7899 101.67 98.06 86.21
Basic Earnings Per Share
53.30%
-0.85
-1.82 -0.91 -0.70 -0.70
Diluted Earnings Per Share
53.30%
-0.85
-1.82 -0.91 -0.70 -0.70
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
100.00%
-
442.93 -185.33 - -
$17.98
price down icon 1.15%
$64.97
price down icon 4.58%
$16.64
price down icon 3.93%
$30.85
price down icon 0.58%
$86.65
price down icon 0.20%
biotechnology ONC
$209.41
price down icon 5.05%
Capitalizzazione:     |  Volume (24 ore):